Kimberly-Clark’s management just told the market its industry will grow half a point slower than it thought three months ago.

That is the number worth sitting with before any of the quarter’s other detail. Not the earnings beat. Not the fire at the Los Angeles distribution centre. Not the diaper allegations that spread across Chinese social media. Management cut its weighted average category growth assumption from 2.5% to 2.0%. That is a statement about the entire essential paper and hygiene sector. It came from the one company with the clearest line of sight into it.

Everything else in the release reads differently once you hold that number first.

The Beat Is Real. The Beat Is Also the Problem

Kimberly-Clark’s headline numbers were genuinely strong on the metric that matters most to a margin-focused board. Adjusted operating profit grew 6.2% to $757 million. Adjusted EPS from continuing operations rose 10.4%, and adjusted EPS attributable to the company hit $2.12, beating consensus of $2.01. Reported gross margin expanded 330 basis points to 38.3%. Adjusted gross margin rose 190 basis points to 38.8%.

Read more

Q2 2026: organic sales grew 2.4%, exactly matching Q2 2025. Net pricing fell from 3.2% to 1.6%. Organic volume rose from -0.2% to +0.8%. Same headline number, different company underneath it.

Colgate-Palmolive’s organic sales grew 2.4% in Q2 2026. They also grew 2.4% in Q2 2025.

That is not a typo, and it is not a coincidence worth skipping past. The identical number is hiding the most useful story in this result. What changed is everything sitting underneath it.

The Number That Didn’t Move, and the Number Underneath It

Net pricing contributed 1.6 percentage points to that 2.4% figure this quarter. A year ago, pricing contributed 3.2 points. Organic volume moved the other way. It was -0.2% in Q2 2025. It is +0.8% now, the third consecutive quarter of sequential global volume improvement.

Run the exchange rate. Colgate gave back roughly 1.6 points of price growth to buy back roughly 1.0 point of volume growth. Call this the volume handback: a company deliberately trading pricing power it built during the inflationary years for the volume it lost in the process. The trade is not free. It is also not obviously a good deal at face value, since price fell further than volume rose. What it buys is a growth mix that survives a slowdown in pricing power far better than a mix built entirely on price would.

Reported net sales reached $5,361 million, up 4.9% from $5,110 million a year earlier. Look at what is actually inside that 4.9%. Foreign exchange contributed 2.4 points, a full swing from a currency headwind a year ago. Roughly half of the headline growth number is currency, not commercial performance. Reported volume came in at 0.9%, helped by a 0.1 point contribution from the Prime100 acquisition. Organic sales growth itself included a planned 0.4-point drag from exiting low-margin private-label pet food manufacturing.

Read more

H1 2026: revenue up 6.5% adjusted like-for-like to €23.78bn. Operating margin hit a record 21.3%. Unilever, LVMH and P&G all had to pick one or the other.

L’Oréal’s operating margin hit 21.3% in the first half of 2026. That is a record for the group.

Margin records are not unusual on their own. Companies hit them by cutting co…

Read more